The Application of Ketamine for Sedation in Patients With Cardiac Arrest
Status:
Not yet recruiting
Trial end date:
2021-06-01
Target enrollment:
Participant gender:
Summary
Recent evidence suggests ketamine may attenuate harmful cellular cascades taking place after
brain injury that result in permanent damage. The investigators are interested in researching
the application of this in the setting of cardiac arrest. Following cardiac arrest, the brain
is deprived oxygen for a period of time, leading to the imitation of these harmful cellular
processes. The investigators hypothesize that patients who receive ketamine as part of their
standard sedation procedures during cardiac arrest treatment have better neurological
functioning compared to those who do not.